What is STERIS's expected EPS for Q1 2027?

Analysts expect STERIS (STE) to report consensus EPS of approximately $2.49 for Q1 2027. Estimates range from $2.44 to $2.58.

What revenue do analysts expect for STERIS in Q1 2027?

The consensus revenue forecast for STERIS (STE) in Q1 2027 is approximately $1.5B. Forecasts range from $1.48B to $1.51B.

How many analysts cover STERIS?

4 analysts contribute to the STERIS (STE) Q1 2027 consensus estimate.

Has STERIS beaten earnings estimates recently?

STERIS beat analyst EPS estimates in 0 of the last 1 quarter. STERIS beat revenue estimates in 0 of 1. In the most recent quarter (Q4 2026), STERIS EPS missed by 0.7% and revenue missed by 0.4%.

When does STERIS report Q1 2027 earnings?

STERIS (STE) is expected to report Q1 2027 earnings on August 5, 2026 after market close.

STE Q1 2027 earnings estimate

Consensus EPS · Q1 2027

$2.49

Consensus revenue · Q1 2027

$1.5B

Analysts

Expected report

Aug 5, 2026

After close

Upcoming earnings

Locks in 13 days 9 hours · AMC: Locks at 4:00 PM ET on report day

Revenue$1.5B$1.5B – $1.5B

EPS$2.49$2.44 – $2.58

What to watch

Analyst ratings: Mixed

Make your prediction

Analyst consensus

Based on estimates from 4 analysts.

Metric	Low	Consensus	High
Revenue	$1.5B	$1.5B	$1.5B
EPS	$2.44	$2.49	$2.58
EBITDA	$426.2M	$427.7M	$429.6M
EBIT	$373.5M	$374.8M	$376.4M
Net income	$244.4M	$245.5M	$246.9M

Revenue$1.5B
EPS$2.49
EBITDA$427.7M
EBIT$374.8M
Net income$245.5M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q4 2026	$1.6B	$1.6B	-0.4%	$2.83	$2.85	-0.7%

Q4 2026-0.4%-0.7%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Grade A — Strong upward revisions

Metric	Now	30d ago	60d ago	90d ago	30d Δ
Revenue	$1.7B	$1.7B	—	—	0%
EPS	$3.16	$3.15	—	—	+0.1%

1 revised up (30d)0 revised down (30d)

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for STERIS (STE) Q1 2027 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 0 analysts.

Low: $269.00
Consensus: $269.50
Median: $269.50
High: $270.00
Current: $210.57
Upside: +28.0%

Upside calculated vs most recent trading price of $210.57.

Analyst ratings

Consensus: Buy — based on 13 analyst ratings.

Buy 11Hold 2

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
May 13, 2026	Keybanc	maintain	Overweight	Overweight
Aug 8, 2025	Morgan Stanley	maintain	Overweight	Overweight
Jul 22, 2025	Keybanc	maintain	Overweight	Overweight
Jul 15, 2025	Morgan Stanley	upgrade	Equal Weight	Overweight
May 19, 2025	Morgan Stanley	maintain	Equal Weight	Equal Weight
May 16, 2025	JMP Securities	maintain	Market Outperform	Market Outperform
May 15, 2025	Stephens & Co.	maintain	Overweight	Overweight
May 12, 2025	Morgan Stanley	maintain	Equal Weight	Equal Weight
Apr 10, 2025	JMP Securities	maintain	Market Outperform	Market Outperform
Apr 7, 2025	Needham	maintain	Hold	Hold

May 13, 2026KeybancOverweight
Aug 8, 2025Morgan StanleyOverweight
Jul 22, 2025KeybancOverweight
Jul 15, 2025Morgan StanleyOverweight
May 19, 2025Morgan StanleyEqual Weight
May 16, 2025JMP SecuritiesMarket Outperform
May 15, 2025Stephens & Co.Overweight
May 12, 2025Morgan StanleyEqual Weight
Apr 10, 2025JMP SecuritiesMarket Outperform
Apr 7, 2025NeedhamHold

Frequently asked questions

STERIS (STE) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

STE Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation